Dhavale H S, Panikkar Vijay, Jadhav Bindoo S, Ghulghule Mangesh, Agari Adita D
J Assoc Physicians India. 2013 Dec;61(12):896-9.
One of the consistent findings among various studies on diabetes has been the prevalence of depression with or without comorbid anxiety among patients of Diabetes Mellitus. Also, numerous other studies have pointed to the negative bearing of the same on blood sugar levels among patients. However there is a lack of data on the outcome of treatment with anti-depressants on the blood glucose level. Considering the ever increasing population of diabetics in our country and the significant causal relationship established by current literature, this study was undertaken.
To study prevalence of depression and anxiety in patients of Type 2 Diabetes Mellitus with an increase in blood glucose levels. To study the socio-demographic profile and role of stressors in patients of Type 2 Diabetes Mellitus. To study the effects of management of depression and anxiety on blood glucose levels in patients of Type 2 Diabetes Mellitus.
100 Consecutive 100 patients diagnosed with Type 2 Diabetes Mellitus(DM) fulfilling the inclusion and exclusion criteria were included in the study. Ethics committee approval was taken for the study.The sociodemographic details of the patients were collected using a specially designed semi-structured proforma. Patients were evaluated for psychiatric disorders using DSM IV TR criteria for diagnosis and Montgomery Asberg Depression Rating Scale (MADRS) and Hamilton Anxiety Rating Scale(HAM-A) were used thereafter to assess the severity of depression and anxiety, respectively. Patients detected with depression and / or anxiety were started on T. Escitalopram (10 mg); keeping the management of DM unchanged. Patients were reviewed after 6 weeks from date of initial assessment and blood glucose levels were repeated. Data thus collected was analysed using SPSS Software.
The prevalence of depression with/without anxiety in the study was 39%. Among depressed patients stressors were found in 84% of patients with social and interpersonal stressors as the more prevalent types. The socio-economic profile showed a female preponderance, lower to middle socioeconomic and educational status and majority were married. 47% of the patients started on T. Escitalopram showed lower fasting and post-lunch blood sugar values on follow up, which was clinically and statistically significant.
在各项糖尿病研究中,一个一致的发现是糖尿病患者中存在抑郁症,无论是否伴有焦虑症。此外,许多其他研究指出这对患者的血糖水平有负面影响。然而,关于抗抑郁药治疗对血糖水平影响的数据却很缺乏。鉴于我国糖尿病患者人数不断增加,且当前文献已确立了显著的因果关系,因此开展了本研究。
研究2型糖尿病患者中抑郁症和焦虑症的患病率以及血糖水平升高情况。研究2型糖尿病患者的社会人口统计学特征及压力源的作用。研究抑郁症和焦虑症的治疗对2型糖尿病患者血糖水平的影响。
连续纳入100例符合纳入和排除标准的2型糖尿病患者。该研究获得了伦理委员会的批准。使用专门设计的半结构化表格收集患者的社会人口统计学详细信息。采用《精神疾病诊断与统计手册》第四版修订版(DSM IV TR)标准对患者进行精神疾病评估,随后使用蒙哥马利-阿斯伯格抑郁评定量表(MADRS)和汉密尔顿焦虑评定量表(HAM - A)分别评估抑郁和焦虑的严重程度。检测出患有抑郁症和/或焦虑症的患者开始服用艾司西酞普兰片(10毫克);糖尿病治疗方案保持不变。从初次评估之日起6周后对患者进行复查,并再次检测血糖水平。使用SPSS软件对收集到的数据进行分析。
本研究中伴有/不伴有焦虑症的抑郁症患病率为39%。在抑郁症患者中,84%的患者存在压力源,其中社会和人际压力源更为普遍。社会经济状况显示女性占多数,社会经济和教育地位为中低水平,大多数已婚。开始服用艾司西酞普兰片的患者中,47%在随访时空腹和午餐后血糖值较低,这在临床和统计学上均具有显著意义。